Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Frontiers in Neurology|November 17, 2022
Burden of illness in people with medically refractory epilepsy who suffer from daily to weekly seizures: 12-month follow-up of participants in the EPISODE studyValérie van Hezik-Wester, Saskia de Groot, Tim Kanters, et al.
Health Policy (Amsterdam, Netherlands)|July 8, 2020
United but divided: Policy responses and people's perceptions in the EU during the COVID-19 outbreakIryna Sabat, Sebastian Neuman-Böhme, Nirosha Elsem Varghese, et al.
Pharmacoeconomics|July 14, 2012
Preference-based health-related quality-of-life outcomes in children with autism spectrum disorders: a comparison of generic instrumentsJ Mick Tilford, Nalin Payakachat, Erica Kovacs, et al.
Health Economics|February 27, 2022
Coverage with evidence development for medical devices in Europe: Can practice meet theory?Michael Drummond, Carlo Federici, Vivian Reckers-Droog, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 27, 2023
Obtaining preference scores for an abbreviated self-completion version of the Teen-Addiction Severity Index (ASC T-ASI) to value therapy outcomes of systemic family interventions: a discrete choice experimentSaskia Schawo, Renske Hoefman, Vivian Reckers-Droog, et al.
Vox Sanguinis|April 9, 2021
Blood donation in times of crisis: Early insight into the impact of COVID-19 on blood donors and their motivation to donate across European countriesTorsten Chandler, Sebastian Neumann-Böhme, Iryna Sabat, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 6, 2023
Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemicSebastian Himmler, Job van Exel, Werner Brouwer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
Practical implications of differential discounting in cost-effectiveness analyses with varying numbers of cohortsJames F O'Mahony, Inge M C M de Kok, Joost van Rosmalen, et al.
Expert Review of Medical Devices|March 29, 2023
An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendationsRosanna Tarricone, Helen Banks, Oriana Ciani, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 12, 2021
Coverage with evidence development schemes for medical devices in Europe: characteristics and challengesCarlo Federici, Vivian Reckers-Droog, Oriana Ciani, et al.
Pageof 17